1209488-58-3

Upstream product

• 1209488-57-2 C₁₈H₂₂N₄O₄ 
• 1200497-71-7 C₁₁H₁₅N₃O₄ 
• 1200497-67-1 C₁₂H₁₇N₃O₄ 
• 1200497-63-7 C₁₂H₁₉N₃O₅ 
• 1200497-59-1 C₁₉H₂₅N₃O₅ 
• 1200497-56-8 1-[2-(benzyloxy)ethyl]-3-(methoxycarbonyl)-1H-pyrazole-5-carboxylic acid 
• 1200497-52-4 3,5-dimethyl 1-[2-(benzyloxy)ethyl]-1H-pyrazole-3,5-dicarboxylate 
• 98-88-4 benzoyl chloride 
• 100-51-6 benzyl alcohol 

Downstream Products

• 1209487-02-4 C₁₂H₁₂N₄O 
• 1209488-59-4 C₁₉H₁₆N₄O₃ 
• 1209487-06-8 C₁₄H₁₅N₅O₂ 
• 1209487-05-7 C₁₉H₁₈N₄O₂ 

Relevant academic research and scientific papers

RING-FUSED AZOLE DERIVATIVE HAVING PI3K-INHIBITING ACTIVITY

It is an object of the present invention to provide a compound or a pharmaceutically acceptable salt thereof which inhibits the activity of PI3K to regulate many biological processes including the growth, differentiation, survival, proliferation, migration, metabolism, and the like of cells and is therefore useful for the prophylaxis/therapy of diseases including inflammatory diseases, arteriosclerosis, vascular/circulatory diseases, cancer/tumors, immune system diseases, cell proliferative diseases, infectious diseases, and the like. The above problem was solved by providing a ring-fused azole compound shown in the present specification, or a pharmaceutically acceptable salt thereof.